{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:20:06Z","timestamp":1781526006109,"version":"3.54.1"},"reference-count":241,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.cytogfr.2017.12.004","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T12:32:57Z","timestamp":1517574777000},"page":"1-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["MicroRNAs link chronic inflammation in childhood to growth impairment and insulin-resistance"],"prefix":"10.1016","volume":"39","author":[{"given":"Francesca","family":"Cirillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Lazzeroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Catellani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Sartori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Amarri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elisabeth","family":"Street","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2017.12.004_bib0005","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1126\/science.1191078","article-title":"Molecular signals of epigenetic states","volume":"330","author":"Bonasio","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0010","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.1190614","article-title":"Epigenetic reprogramming in plant and animal development","volume":"330","author":"Feng","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0015","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1126\/science.293.5532.1103","article-title":"Genes, genetics, and epigenetics: a correspondence","volume":"293","author":"Wu","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0020","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0025","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature03049","article-title":"Processing of primary microRNAs by the Microprocessor complex","volume":"432","author":"Denli","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0030","doi-asserted-by":"crossref","first-page":"17649","DOI":"10.1074\/jbc.M611768200","article-title":"Human TRBP and PACT directly interact with each other and associate with dicer to facilitate the production of small interfering RNA","volume":"282","author":"Kok","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0035","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nature03868","article-title":"TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing","volume":"436","author":"Chendrimada","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cmet.2006.05.009","article-title":"MicroRNAs: a new class of regulatory genes affecting metabolism","volume":"4","author":"Kr\u00fctzfeldt","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0045","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tcb.2006.12.007","article-title":"Repression of protein synthesis by miRNAs: how many mechanisms?","volume":"17","author":"Pillai","year":"2007","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0050","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrg2290","article-title":"Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?","volume":"9","author":"Filipowicz","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0055","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0060","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/0092-8674(93)90530-4","article-title":"Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans","volume":"75","author":"Wightman","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0065","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrneph.2011.26","article-title":"MicroRNAs as mediators and therapeutic targets in chronic kidney disease","volume":"7","author":"Lorenzen","year":"2011","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0070","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.trsl.2011.01.008","article-title":"MicroRNAs and liver disease","volume":"157","author":"Kerr","year":"2011","journal-title":"Transl. Res."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0075","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrg3074","article-title":"Non-coding RNAs in human disease","volume":"12","author":"Esteller","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0080","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.devcel.2006.09.009","article-title":"The diverse functions of microRNAs in animal development and disease","volume":"11","author":"Kloosterman","year":"2006","journal-title":"Dev. Cell"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0085","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers","volume":"6","author":"Calin","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0090","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers","volume":"435","author":"Lu","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0095","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.molcel.2007.06.017","article-title":"MicroRNA targeting specificity in mammals: determinants beyond seed pairing","volume":"27","author":"Grimson","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0100","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1101\/gad.1184404","article-title":"Specificity of microRNA target selection in translational repression","volume":"18","author":"Doench","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0105","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nm1784","article-title":"Expression of a noncoding RNA is elevated in Alzheimer\u2019s disease and drives rapid feed-forward regulation of beta-secretase","volume":"14","author":"Faghihi","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0110","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1042\/BST0341148","article-title":"Does everything now make (anti)sense?","volume":"34","author":"Timmons","year":"2006","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0115","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosomemediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0120","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.gene.2016.01.039","article-title":"Role of microRNA 21 in diabetes and associated\/related diseases","volume":"582","author":"Sekar","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0125","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1016\/j.febslet.2005.04.024","article-title":"Adaptor usage and Toll-like receptor signaling specificity","volume":"579","author":"Dunne","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0130","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1006\/cyto.2002.0895","article-title":"Transcriptional and post-transcriptional control of gene expression in inflammation","volume":"20","author":"Kracht","year":"2002","journal-title":"Cytokine"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0135","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1073\/pnas.0811073106","article-title":"MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocytederived dendritic cells","volume":"106","author":"Ceppi","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0140","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1073\/pnas.0610731104","article-title":"MicroRNA-155 is induced during the macrophage inflammatory response","volume":"104","author":"O\u2019Connell","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0145","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2567.2009.03092.x","article-title":"MicroRNA in the immune system, microR NA as an immune system","volume":"127","author":"Lu","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0150","doi-asserted-by":"crossref","first-page":"7080","DOI":"10.1073\/pnas.0702409104","article-title":"miR-150 a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely","volume":"104","author":"Zhou","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0155","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1126\/science.1091903","article-title":"MicroRNAs modulate hematopoietic lineage differentiation","volume":"303","author":"Chen","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0160","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1210\/en.2014-1983","article-title":"Insulin-Like growth factor-Independent effects of growth hormone on growth plate chondrogenesis and longitudinal bone growth","volume":"156","author":"Wu","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0165","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ghir.2015.09.002","article-title":"Growth hormone signaling pathways","volume":"28","author":"Carter-Su","year":"2016","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0170","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ctrv.2017.08.012","article-title":"IGF system targeted therapy: therapeutic opportunities for ovarian cancer","volume":"60","author":"Liefers-Visser","year":"2017","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0175","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18091878","article-title":"Inflammatory diseases and growth: effects on the GH-IGF axis and on growth plate","volume":"18","author":"Cirillo","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0180","series-title":"The IGF System","first-page":"143","article-title":"IGF-I receptor function: transducing the IGF-I signal into intracellular events","author":"Blakesley","year":"1999"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9258(17)42297-6","article-title":"The insulin signaling system","volume":"269","author":"White","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0190","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1530\/EJE-08-0081","article-title":"Homozygous and heterozygous expression of a novel mutation of the acid-labile subunit","volume":"159","author":"van Duyvenvoorde","year":"2008","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0195","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1210\/jc.2005-2842","article-title":"Total absence of functional acid labile subunit, resulting in severe insulin-like growth factor deficiency and moderate growth failure","volume":"91","author":"Hwa","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0200","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1677\/joe.0.1700063","article-title":"The acid-labile subunit (ALS) of the 150\u202fkDa IGF-binding protein complex: an important but forgotten component of the circulating IGF system","volume":"170","author":"Boisclair","year":"2001","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0205","series-title":"Endocrine Society\u2019s 97th Annual Meeting and Expo","article-title":"A new syndrome of short stature, mild microcephaly, skeletal abnormalities and high circulating IGF1, IGFBP3 and ALS associated with a homozygous mutation in the gene for pregnancy-associated plasma protein A2 (PAPP-A2, pappalysin2)","author":"Mu\u00f1oz-Calvo","year":"2015"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0210","first-page":"339","article-title":"Deficiency of the insulin-like growth factor-binding protein acid-labile subunit (ALS) of the circulating ternary complex in children with short stature","volume":"7","author":"Domen\u00e9","year":"2010","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0215","first-page":"3","article-title":"Insulin-like growth factors and their binding proteins: biological actions","volume":"16","author":"Jones","year":"1995","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0220","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrm1837","article-title":"Critical nodes in signalling pathways: insights into insulin action","volume":"7","author":"Taniguchi","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0225","doi-asserted-by":"crossref","first-page":"E1262","DOI":"10.1152\/ajpendo.00609.2005","article-title":"Grb10 mediates insulin-stimulated degradation of the insulin receptor: a mechanism of negative regulation","volume":"290","author":"Ramos","year":"2006","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0230","doi-asserted-by":"crossref","first-page":"39311","DOI":"10.1074\/jbc.M304599200","article-title":"Growth factor receptor-binding protein 10 (Grb10) as a partner of phosphatidylinositol 3-kinase in metabolic insulin action","volume":"278","author":"Deng","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0235","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000329991","article-title":"Impact of inflammatory bowel disease on pubertal growth","volume":"76","author":"Mason","year":"2011","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0240","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1210\/er.2015-1026","article-title":"Growth and the growth hormone-insulin like growth factor 1 axis in children with chronic inflammation: current evidence, gaps in knowledge, and future directions","volume":"37","author":"Wong","year":"2016","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0245","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/nrgastro.2014.102","article-title":"Growth problems in children with IBD","volume":"11","author":"Sanderson","year":"2014","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0250","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1124\/pr.109.002469","article-title":"Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases?","volume":"62","author":"Smith","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0255","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1172\/JCI119207","article-title":"Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I-A model for stunted growth in children with chronic inflammation","volume":"99","author":"De Benedetti","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0260","first-page":"64","article-title":"How proinflammatory cytokines may impair growth and cause muscle wasting","volume":"67","author":"Thissen","year":"2007","journal-title":"Horm. Res."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0265","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/jbmr.1544","article-title":"SOCS2 is the critical regulator of GH action in murine growth plate chondrogenesis","volume":"27","author":"Pass","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0270","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.1074\/jbc.275.6.3841","article-title":"Role of the suppressor of cytokine signaling-3 in mediating the inhib- itory effects of interleukin-1 beta on the growth hormone-de- pendent transcription of the acid-labile subunit gene in liver cells","volume":"275","author":"Boisclair","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0275","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/pr.2014.84","article-title":"Inhibition of IGF1-related intracellular signaling path- ways by proinflammatory cytokines in growth plate chondrocytes","volume":"76","author":"Choukair","year":"2014","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0280","doi-asserted-by":"crossref","first-page":"7713","DOI":"10.4049\/jimmunol.172.12.7713","article-title":"IL-1beta impairs insulin-like growth factor 1-induced differentiation and downstream activation signals of the insulin-like growth factor 1 receptor in myoblasts","volume":"172","author":"Broussard","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0285","doi-asserted-by":"crossref","first-page":"E1025","DOI":"10.1210\/jc.2010-3023","article-title":"Prevalence and incidence of diabetes mellitus in GH-treated children and adolescents: analysis from the GeNeSIS observational research program","volume":"96","author":"Child","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0290","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0295","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.diabres.2014.04.006","article-title":"Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes","volume":"105","author":"Esser","year":"2014","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0300","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev-physiol-021909-135846","article-title":"Macrophages inflammation, and insulin resistance","volume":"72","author":"Olefsky","year":"2010","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0305","doi-asserted-by":"crossref","first-page":"5881","DOI":"10.1074\/jbc.M114.624759","article-title":"Tumor necrosis factor (TNF)-\u03b1-induced repression of GKAP42 protein levels through cGMP-dependent kinase (cGK)-I\u03b1 causes insulin resistance in 3T3-L1 adipocytes","volume":"290","author":"Ando","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0310","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.nut.2013.11.016","article-title":"Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation","volume":"30","author":"Andrade","year":"2014","journal-title":"Nutrition"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0315","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI25102","article-title":"Inflammation, stress, and diabetes","volume":"115","author":"Wellen","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0320","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0962-8924(01)02064-5","article-title":"Signal transduction by tumor necrosis factor and its relatives","volume":"11","author":"Baud","year":"2001","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0325","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nature02866","article-title":"Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity","volume":"431","author":"Um","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0330","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1210\/en.2004-0921","article-title":"Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance","volume":"146","author":"Khamzina","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0335","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1126\/science.1199484","article-title":"Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling","volume":"332","author":"Yu","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0340","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jpeds.2013.02.026","article-title":"Pubertal height velocity and associations with prepubertal and adult heights in cystic fibrosis","volume":"163","author":"Zhang","year":"2013","journal-title":"J. Pediatr."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0345","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1159\/000228581","article-title":"Growth retardation in early-onset inflammatory bowel disease: should we monitor and treat these patients differently?","volume":"27","author":"Griffiths","year":"2009","journal-title":"Dig. Dis."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0350","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000229758","article-title":"Natural history of growth and body composition in juvenile idiopathic arthritis","volume":"72","author":"Bechtold","year":"2009","journal-title":"Horm. Res."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0355","unstructured":"World Health Organization, Genomic Resource Centre, Cystic Fibrosis. <http:\/\/www.who.int\/genomics\/public\/geneticdiseases\/en\/index2.html#CF\/>. (Accessed 18 December 2017)."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0360","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1210\/jc.2016-2431","article-title":"miR-146a miR-155, miR-370, and miR-708 are CFTR-dependent, predicted FOXO1 regulators and change at onset of CFRDs","volume":"101","author":"Montanini","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0365","doi-asserted-by":"crossref","first-page":"21305","DOI":"10.1074\/jbc.M115.649087","article-title":"Activation of human toll-like receptor 4 (TLR4)\u00b7myeloid differentiation factor 2 (MD-2) by hypoacylated lipopolysaccharide from a clinical isolate of Burkholderia cenocepacia","volume":"290","author":"Di Lorenzo","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0370","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s11892-014-0511-3","article-title":"Cystic fibrosis related diabetes","volume":"4","author":"O\u2019Shea","year":"2014","journal-title":"Curr. Diabetes Rep."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0375","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2265.2008.03387.x","article-title":"The IGF system and cytokine interactions and relationships with longitudinal growth in prepubertal patients with cystic fibrosis","volume":"70","author":"Street","year":"2009","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0380","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0022-3476(98)70024-1","article-title":"Growth status in children with cystic fibrosis based on the National Cystic Fibrosis Patient Registry data: evaluation of various criteria used to identify malnutrition","volume":"132","author":"Lai","year":"1998","journal-title":"J. Pediatr."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0385","first-page":"246","article-title":"Insulin production and resistance in cystic fibrosis: effect of age, disease activity, and genotype","volume":"35","author":"Street","year":"2012","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0390","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/archdischild-2011-301069","article-title":"Growth during puberty in cystic fibrosis: a retrospective evaluation of a French cohort","volume":"97","author":"Bournez","year":"2012","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0395","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1651-2227.2003.tb02571.x","article-title":"Pubertal growth and development in cystic fibrosis: a retrospective review","volume":"92","author":"Aswani","year":"2003","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0400","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1530\/eje.1.02064","article-title":"Inflammation is a modulator of the insulin-like growth factor (IGF)\/IGF-binding protein system inducing reduced bioactivity of IGFs in cystic fibrosis","volume":"154","author":"Street","year":"2006","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0405","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jcf.2012.08.003","article-title":"Growth retardation and reduced growth hormone secretion in cystic fibrosis. Clinical observations from three CF centers","volume":"12","author":"Ciro","year":"2013","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0410","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1365-2265.2002.01484.x","article-title":"The relationship between insulin secretion, the insulin-like growth factor axis and growth in children with cystic fibrosis","volume":"56","author":"Ripa","year":"2002","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0415","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0140-6736(09)62161-9","article-title":"Comparative demographics of the European cystic fibrois population: a cross-sectional database analysis","volume":"375","author":"McCormick","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0420","doi-asserted-by":"crossref","first-page":"509437","DOI":"10.1155\/2012\/509437","article-title":"Endoplasmic reticulum stress and insulin biosynthesis: a review","volume":"2012","author":"Kim","year":"2012","journal-title":"Exp. Diabetes Res."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0425","doi-asserted-by":"crossref","first-page":"18000","DOI":"10.3390\/ijms151018000","article-title":"FOXO1 content is reduced in cystic fibrosis and increases with IGF-I treatment","volume":"15","author":"Smerieri","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0430","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1210\/jc.2015-3730","article-title":"HMGB1 is increased by CFTR loss of function is lowered by insulin, and increases in vivo at onset of CFRD","volume":"101","author":"Montanini","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0435","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1749-6632.2010.05879.x","article-title":"Modifier genes in Mendelian disorders: the example of cystic fibrosis","volume":"1214","author":"Cutting","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0440","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrendo.2013.157","article-title":"The role of FOXO1 in \u03b2-cell failure and type 2 diabetes mellitus","volume":"9","author":"Kitamura","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0445","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.4049\/jimmunol.0902669","article-title":"miR-126 is downregulated in cystic fibrosis airway epithelial cells and regulates TOM1 expression","volume":"184","author":"Oglesby","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0450","doi-asserted-by":"crossref","first-page":"11604","DOI":"10.1074\/jbc.M110.198390","article-title":"Elevated miR-155 promotes inflammation in cystic fibrosis by driving hyperexpression of interleukin-8","volume":"286","author":"Bhattacharyya","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0455","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.bbrc.2013.03.025","article-title":"Regulation of miR-155 biogenesis in cystic fibrosis lung epithelial cells: antagonistic role of two mRNA-destabilizing proteins, KSRP and TTP","volume":"433","author":"Bhattacharyya","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0460","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1183\/09031936.00163414","article-title":"miR-17 overexpression in cystic fibrosis airway epithelial cells decreases interleukin-8 production","volume":"46","author":"Oglesby","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0465","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jcf.2013.03.007","article-title":"Elevated levels of miR-145 correlate with SMAD3 down-regulation in cystic fibrosis patients","volume":"12","author":"Megiorni","year":"2013","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0470","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1056\/NEJM199109263251306","article-title":"Inflammatory bowel disease (1)","volume":"325","author":"Podolsky","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0475","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2004.01.063","article-title":"Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences","volume":"126","author":"Loftus","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0480","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1136\/gut.34.7.939","article-title":"Growth and clinical course of children with Crohn\u2019s disease","volume":"34","author":"Griffiths","year":"1993","journal-title":"Gut"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0485","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/adc.52.8.627","article-title":"Crohn\u2019s disease in childhood","volume":"52","author":"O\u2019Donoghue","year":"1977","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0490","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1542\/peds.55.4.459","article-title":"Growth retardation in children with ulcerative colitis: the effect of medical and surgical therapy","volume":"55","author":"Berger","year":"1975","journal-title":"Paediatrics"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0495","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1651-2227.1990.tb11608.x","article-title":"Growth and development in chronic inflammatory bowel disease","volume":"366","author":"Kirschner","year":"1990","journal-title":"Acta Paediatr. Scand."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0500","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1136\/gut.46.5.695","article-title":"Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis","volume":"46","author":"Ballinger","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0505","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cyto.2014.07.250","article-title":"Effect of Astragalus polysaccharides on expression of TNF-\u03b1, IL-1\u03b2 and NFATc4 in a rat model of experimental colitis","volume":"70","author":"Yang","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0510","first-page":"159","article-title":"Relationships between serum IGF-1 IGFBP-2, interleukin-1beta and interleukin-6 in inflammatory bowel disease","volume":"61","author":"Street","year":"2004","journal-title":"Horm. Res."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0515","first-page":"7","article-title":"Fundamental mechanisms of growth failure in inflammatory bowel disease","volume":"58","author":"Ballinger","year":"2002","journal-title":"Horm. Res."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0520","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/pr.2013.114","article-title":"Circulating leptin and adiponectin and their relation to glucose metabolism in children with Crohn\u2019s disease and ulcerative colitis","volume":"74","author":"Chouliaras","year":"2013","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0525","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1055\/s-0034-1374587","article-title":"Systemic metabolic signaling in acute and chronic gastrointestinal inflammation of inflammatory bowel diseases","volume":"46","author":"Karrash","year":"2014","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0530","doi-asserted-by":"crossref","first-page":"5468","DOI":"10.1210\/jc.2003-030608","article-title":"Effects of growth hormone secretion on body composition in patients with Crohn\u2019s disease","volume":"88","author":"Katznelson","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0535","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ibd.21450","article-title":"Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn\u2019s disease","volume":"17","author":"Wu","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0540","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031241","article-title":"Genome-wide maps of circulating miRNA biomarkers for ulcerative colitis","volume":"7","author":"Duttagupta","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0545","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/MPG.0b013e31822200cc","article-title":"Circulating microRNA is a biomarker of pediatric Crohn disease","volume":"53","author":"Zahm","year":"2011","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0550","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.autrev.2010.07.002","article-title":"MicroRNAs in autoimmunity and inflammatory bowel disease: crucial regulators in immune response","volume":"11","author":"Iborra","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0555","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.crohns.2012.02.006","article-title":"Circulating MicroRNA in inflammatory bowel disease","volume":"6","author":"Paraskevi","year":"2012","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0560","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/jgh.12523","article-title":"Serum microRNA levels in patients with Crohn\u2019s disease during induction therapy by infliximab","volume":"29","author":"Fujioka","year":"2014","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0565","doi-asserted-by":"crossref","DOI":"10.1186\/s12865-015-0069-0","article-title":"MicroRNA signatures differentiate Crohn\u2019s disease from ulcerative colitis","volume":"16","author":"Schaefer","year":"2015","journal-title":"BMC. Immunol."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0570","article-title":"Circulating MicroRNA223 is a new biomarker for inflammatory bowel disease","volume":"95","author":"Wang","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0575","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1097\/MIB.0000000000000547","article-title":"Assessment of circulating MicroRNAs for the diagnosis and disease activity evaluation in patients with ulcerative colitis by using the nanostring technology","volume":"21","author":"Polytarchou","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0580","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/cea.12135","article-title":"Targeting translational control as a novel way to treat inflammatory disease: the emerging role of microRNAs","volume":"43","author":"Plank","year":"2013","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0585","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/art.1780180309","article-title":"Pathogenic implications of age of onset in juvenile rheumatoid arthritis","volume":"18","author":"Sullivan","year":"1975","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0590","first-page":"1991","article-title":"Revision of the proposed classification criteria for juvenile idiopathic arthritis","volume":"25","author":"Petty","year":"1998","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0595","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s00296-014-3022-2","article-title":"Growth abnormalities in children and adolescents with juvenile idiopathic arthritis","volume":"34","author":"Bechtold","year":"2014","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0600","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ghir.2007.05.002","article-title":"IGF-I signalling in bone growth: inhibitory actions of dexameth- asone and IL-1 beta","volume":"17","author":"MacRae","year":"2007","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0605","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1093\/rheumatology\/41.12.1440","article-title":"Long-term follow-up of 246 adults with juvenile idiopathic arthritis: social function, relationships and sexual activity","volume":"41","author":"Packham","year":"2002","journal-title":"Rheumatology"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0610","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0197-0070(88)80006-8","article-title":"The timing of menarche in juvenile rheumatoid arthritis","volume":"9","author":"Fraser","year":"1988","journal-title":"J. Adolesc. Health Care"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0615","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1152\/ajpcell.2000.279.6.C1906","article-title":"Inhibition of growth hormone action in models of inflammation","volume":"279","author":"Bergad","year":"2000","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0620","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1096-6374(00)80003-9","article-title":"Inflammatory cytokines and acquired growth hormone resistance","volume":"10","author":"von Laue","year":"2000","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0625","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1210\/endo.142.11.8511","article-title":"Effect of IL-6 on IGF binding protein-3: a study in IL-6 trans- genic mice and in patients with systemic juvenile idiopathic arthritis","volume":"142","author":"De Benedetti","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0630","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/rheumatology\/35.4.350","article-title":"Anterior pituitary function in patients with newly diagnosed rheumatoid arthritis","volume":"35","author":"Templ","year":"1996","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0635","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1152\/ajpendo.00502.2006","article-title":"Experimental arthritis inhibits the insulin-like growth factor-I axis and induces muscle wasting through cyclooxygenase-2 activation","volume":"292","author":"Granado","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0640","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ghir.2008.01.006","article-title":"Inflammatory cytokines in juvenile idiopathic arthritis: effects on physical growth and the insulin-like-growth factor axis","volume":"18","author":"Wong","year":"2008","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0645","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/S0024-3205(99)00472-5","article-title":"Chronic inflammation inhibits GH secretion and alters the serum insulin-like growth factor system in rats","volume":"65","author":"Lopez-Calder\u00f3n","year":"1999","journal-title":"Life Sci."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0650","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000334646","article-title":"Changes in growth hormone receptor gene expression during therapy in children with juvenile idiopathic arthritis","volume":"77","author":"Bozzola","year":"2012","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0655","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jbspin.2016.09.001","article-title":"Rheumatoid arthritis, insulin resistance, and diabetes","volume":"84","author":"Nicolau","year":"2017","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0660","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002552","article-title":"Prevalence of undiagnosed diabetes in rheumatoid arthritis: an OGTT study","volume":"95","author":"Ursini","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0665","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1590\/S0482-50042010000200008","article-title":"Metabolic syndrome and juvenile idiopathic arthritis","volume":"50","author":"Zanette Cde","year":"2010","journal-title":"Rev. Bras. Reumatol."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0670","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1159\/000313589","article-title":"Moderate deterioration in glucose tolerance during high-dose growth hormone therapy in glucocorticoid-treated patients with juvenile idiopathic arthritis","volume":"73","author":"Bismuth","year":"2010","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0675","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1210\/jc.2003-031005","article-title":"Adipocytokines and insulin resistance","volume":"89","author":"Pittas","year":"2004","journal-title":"J Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0680","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1155\/2013\/436702","article-title":"Subclinical cardiovascular system changes in obese patients with juvenile idiopathic arthritis","volume":"2013","author":"G\u0142owi\u0144ska-Olszewska","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0685","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.autrev.2009.11.018","article-title":"Environmental factors and the geoepidemiology of juvenile idiopathic arthritis","volume":"9","author":"Berkun","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0690","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1007\/s10067-015-2922-1","article-title":"Serum microRNAs as potential biomarkers of juvenile idiopathic arthritis","volume":"34","author":"Kamiya","year":"2015","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0695","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3109\/14397595.2015.1060663","article-title":"Differential plasma microRNAs expression in juvenile idiopathic arthritis","volume":"26","author":"Ma","year":"2016","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0700","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(99)00243-3","article-title":"An iceberg of childhood coeliac disease in the Netherlands","volume":"353","author":"Csizmadia","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0705","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/01.mop.0000133637.64414.20","article-title":"Celiac disease as a cause of growth retardation in childhood","volume":"16","author":"Catassi","year":"2004","journal-title":"Curr. Opin. Pediatr."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0710","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/BF00442220","article-title":"Effects of a gluten-free diet on catch-up growth and height prognosis in coeliac children with growth retardation recognized after the age of 5 years","volume":"147","author":"De Luca","year":"1998","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0715","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2015.25","article-title":"Systematic growth monitoring for the early detection of celiac disease in children","volume":"169","author":"Saari","year":"2015","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0720","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1136\/adc.2004.057851","article-title":"Short stature and the probability of coeliac disease, in the absence of gastrointestinal symptoms","volume":"89","author":"van Rijn","year":"2004","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0725","first-page":"499","article-title":"Insulin-like growth factor-I is a marker for the nutritional state","volume":"13","author":"Hawkes","year":"2015","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0730","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000184187","article-title":"Hormonal and nutritional regulation of IGF-I and its binding proteins","volume":"42","author":"Underwood","year":"1994","journal-title":"Horm. Res."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0735","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/MPG.0b013e3180de5e0a","article-title":"Growth hormone treatment in prepubertal children with celiac disease and growth hormone deficiency","volume":"45","author":"Giovenale","year":"2007","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0740","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00005176-199411000-00004","article-title":"Insulin-like growth factor-I in celiac disease","volume":"19","author":"Weile","year":"1994","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0745","first-page":"57","article-title":"Catch-up growth and endocrine changes in childhood celiac disease","volume":"58","author":"Boersma","year":"2002","journal-title":"Horm. Res."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0750","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2265.2007.02992.x","article-title":"Changes and relationships of IGFS and IGFBPS and cytokines in coeliac disease at diagnosis and on gluten-free diet","volume":"68","author":"Street","year":"2008","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0755","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.3748\/wjg.v19.i34.5658","article-title":"Cardiovascular disease risk factor profiles in children with celiac disease on gluten-free diets","volume":"19","author":"Norsa","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0760","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1097\/MEG.0000000000000437","article-title":"Increased arterial stiffness and its relationship with inflammation insulin, and insulin resistance in celiac disease","volume":"27","author":"Korkmaz","year":"2015","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0765","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1053\/j.gastro.2010.07.040","article-title":"MicroRNAs control intestinal epithelial differentiation, architecture, and barrier function","volume":"139","author":"McKenna","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0770","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029094","article-title":"MicroRNA-449a overexpression, reduced NOTCH1 signals and scarce goblet cells characterize the small intestine of celiac patients","volume":"6","author":"Capuano","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0775","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1042\/CS20130248","article-title":"MicroRNA profiles in celiac patients distinguish different clinical phenotypes and are modulated by gliadin peptides in primary duodenal fibroblasts","volume":"126","author":"Vaira","year":"2014","journal-title":"Clin. Sci."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0780","doi-asserted-by":"crossref","DOI":"10.1007\/s12263-015-0482-2","article-title":"miRNA-regulated gene expression differs in celiac disease patients according to the age of presentation","volume":"10","author":"Buoli Comani","year":"2015","journal-title":"Genes Nutr."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0785","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1155\/2011\/269853","article-title":"Intrauterine growth retardation and nonalcoholic Fatty liver disease in children","volume":"2011","author":"Alisi","year":"2011","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0790","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4137\/CMPed.S40070","article-title":"Intrauterine growth restriction: antenatal and postnatal aspects","volume":"10","author":"Sharma","year":"2016","journal-title":"Clin. Med. Insights Pediatr."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0795","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1196\/annals.1290.017","article-title":"Endocrine-related causes and consequences of intrauterine growth retardation","volume":"997","author":"Kanaka-Gantenbein","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0800","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJM199610313351805","article-title":"Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene","volume":"335","author":"Woods","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0805","first-page":"59","article-title":"Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r)","volume":"75","author":"Liu","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0810","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1203\/00006450-199511000-00017","article-title":"Growth in full-term small-for-gestational-age infants: from birth to final height","volume":"38","author":"Karlberg","year":"1995","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0815","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/bdrb.20249","article-title":"Maternal-placental insulin-like growth factor (IGF) signaling and its importance to normal embryo-fetal development","volume":"89","author":"Bowman","year":"2010","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0820","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029562","article-title":"Effects of cord serum insulin, IGF-II, IGFBP-2, IL-6 and cortisol concentrations on human birth weight and length: pilot study","volume":"6","author":"Smerieri","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0825","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.3390\/nu7021202","article-title":"Altered fetal skeletal muscle nutrient metabolism following an adverse in utero environment and the modulation of later life insulin sensitivity","volume":"7","author":"Dunlop","year":"2015","journal-title":"Nutrients"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0830","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1530\/EJE-10-0752","article-title":"Impairment of insulin receptor signal transduction in placentas of intra-uterine growth-restricted newborns and its relationship with fetal growth","volume":"164","author":"Street","year":"2011","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0835","first-page":"693","article-title":"Association of placental insulin, total and activated insulin receptor contents, cortisol and IL-6 concentrations with human birth weight and length: pilot study","volume":"26","author":"Smerieri","year":"2012","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0840","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.placenta.2013.04.009","article-title":"Increased levels of microRNA-424 are associated with the pathogenesis of fetal growth restriction","volume":"34","author":"Huang","year":"2013","journal-title":"Placenta"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0845","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.placenta.2013.04.007","article-title":"Differentially expressed microRNAs and affected biological pathways revealed by modulated modularity clustering (MMC) analysis of human preeclamptic and IUGR placentas","volume":"34","author":"Guo","year":"2013","journal-title":"Placenta"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0850","doi-asserted-by":"crossref","DOI":"10.1095\/biolreprod.111.094797","article-title":"Placental TonEBP\/NFAT5 osmolyte regulation in an ovine model of intrauterine growth restriction","volume":"86","author":"Arroyo","year":"2012","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0855","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.05005","article-title":"Predicting effective microRNA target sites in mammalian mRNAs","volume":"4","author":"Agarwal","year":"2015","journal-title":"eLife"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0860","doi-asserted-by":"crossref","first-page":"D153","DOI":"10.1093\/nar\/gku1215","article-title":"DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA: mRNA interactions","volume":"43","author":"Vlachos","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0865","doi-asserted-by":"crossref","first-page":"D447","DOI":"10.1093\/nar\/gku1003","article-title":"STRING v10: protein-protein interaction networks integrated over the tree of life","volume":"43","author":"Szklarczyk","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0870","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/ng.2331","article-title":"De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes","volume":"44","author":"Rivi\u00e8re","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0875","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/hmg\/dds440","article-title":"Somatic gain-of-function mutations in PIK3CA in patients with macrodactyly","volume":"22","author":"Rios","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0880","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000456544","article-title":"Short stature in a boy with multiple early-onset autoimmune conditions due to a STAT3 activating mutation: could intracellular growth hormone signalling be compromised?","volume":"88","author":"Sediva","year":"2017","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0885","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000313415","article-title":"Cytoplasmic and nuclear STAT3 in GH-stimulated fibroblasts of children with idiopathic short stature","volume":"74","author":"Mart\u00ednez Pinto","year":"2010","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0890","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ydbio.2007.10.001","article-title":"Trps1 regulates proliferation and apoptosis of chondrocytes through Stat3 signaling","volume":"312","author":"Suemoto","year":"2007","journal-title":"Dev. Biol."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0895","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ajhg.2013.06.005","article-title":"Mutations in PIK3R1 cause SHORT syndrome","volume":"93","author":"Dyment","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0900","doi-asserted-by":"crossref","first-page":"AB172","DOI":"10.1016\/j.jaci.2016.12.564","article-title":"A child with hyper-IgM syndrome and multiple endocrinopathies with mutations in signal transducer and activator 5B (STAT5B), phosphatidylinositol 3-kinase catalytic subunit delta (PIK3CD) and phosphatidylinositol 3-kinase regulatory subunit 1 (PIK3R1)","volume":"139","author":"Curtiss","year":"2017","journal-title":"J. Clin. Immun."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0905","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.jaci.2016.12.957","article-title":"JAK1 gain-of-function causes an autosomal dominant immune dysregulatory and hypereosinophilic syndrome","volume":"139","author":"Del Bel","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0910","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1677\/JOE-09-0328","article-title":"A novel spontaneous mutation of Irs1 in mice results in hyperinsulinemia, reduced growth, low bone mass and impaired adipogenesis","volume":"204","author":"DeMambro","year":"2010","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0915","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1210\/js.2017-00294","article-title":"Increased IRS2 mRNA expression in SGA neonates: PCR analysis of insulin\/IGF signaling in cord blood","volume":"1","author":"Fujimoto","year":"2017","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0920","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1210\/jc.2005-0995","article-title":"PTPN11 mutations are associated with mild growth hormone resistance in individuals with Noonan syndrome","volume":"90","author":"Binder","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0925","doi-asserted-by":"crossref","first-page":"12699","DOI":"10.1038\/s41598-017-12767-9","article-title":"SHP2 regulates the osteogenic fate of growth plate hypertrophic chondrocytes","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0930","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7243\/2052-8000-2-1","article-title":"Growth hormone and noonan syndrome: update in dysfunctional signaling aspects and in therapy for short stature","volume":"2","author":"Raynal","year":"2014","journal-title":"Horm. Stud."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0935","series-title":"Endocrine Society\u2019s 96th Annual Meeting and Expo","article-title":"SAT-0139: a novel heterozygous insulin-like growth factor 1 receptor (IGF1R) gene deletion in a child with short stature and neurofibromatosis 1","author":"Golekoh","year":"2014"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0940","doi-asserted-by":"crossref","first-page":"E243","DOI":"10.1210\/jc.2011-2142","article-title":"Severe short stature caused by novel compound heterozygous mutations of the insulin-like growth factor 1 receptor (IGF1R)","volume":"97","author":"Fang","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0945","first-page":"374","article-title":"Molecular mechanisms underlying insulin-like growth factor action: how mutations in the GH: IGF axis lead to short stature","volume":"8","author":"Forbes","year":"2011","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0950","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1002\/ajmg.a.34310","article-title":"Short stature due to 15q26 microdeletion involving IGF1R: report of an additional case and review of the literature","volume":"155","author":"Rudaks","year":"2011","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0955","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1210\/jc.2008-1903","article-title":"Familial short stature caused by haploinsufficiency of the insulin-like growth factor i receptor due to nonsense-mediated messenger ribonucleic acid decay","volume":"94","author":"Fang","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0960","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13023-016-0465-4","article-title":"FGFR3 gene mutation plus GRB10 gene duplication in a patient with achondroplasia plus growth delay with prenatal onset","volume":"11","author":"Yuan","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0965","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.placenta.2015.09.006","article-title":"Placental expression of the insulin receptor binding protein GRB10: relation to human fetoplacental growth and fetal gender","volume":"36","author":"Mukhopadhyay","year":"2015","journal-title":"Placenta"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0970","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1172-5-19","article-title":"Silver-Russell syndrome: genetic basis and molecular genetic testing","volume":"5","author":"Eggermann","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0975","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00467-009-1339-y","article-title":"Temporal and spatial expression of a growth-regulated network of imprinted genes in growth plate","volume":"25","author":"Andrade","year":"2010","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0980","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/sj.ejhg.5200583","article-title":"Maternal repression of the human GRB10 gene in the developing central nervous system; evaluation of the role for GRB10 in Silver-Russell syndrome","volume":"9","author":"Hitchins","year":"2001","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0985","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1086\/302997","article-title":"Imprinting of human GRB10 and its mutations in two patients with Russell-Silver syndrome","volume":"67","author":"Yoshihashi","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0990","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1086\/302717","article-title":"Duplication of 7p11.2-p13 including GRB10, in Silver-Russell syndrome","volume":"66","author":"Monk","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib0995","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa022926","article-title":"Growth hormone insensitivity associated with a STAT5b mutation","volume":"349","author":"Kofoed","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1000","article-title":"Novel dominant-negative STAT5B mutations associated with growth hormone insensitivity and severe short stature: expanding the clinical spectrum of STAT5B deficiency","volume":"37","author":"Gevers","year":"2016","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1005","first-page":"P65","article-title":"A heterozygous STAT5B variant in a family with short stature and transient hyperprolactinaemia: a possible dominant negative effect","volume":"36","author":"Pease-Gevers","year":"2014","journal-title":"Endocr. Abstr."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1010","series-title":"Endocrine Society\u2019s 96th Annual Meeting and Expo","article-title":"Severe short stature and GH insensitivity due to a de novo heterozygous STAT5B missense mutation","author":"Klammt","year":"2014"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1015","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jpeds.2010.12.042","article-title":"STAT5b deficiency: an unsuspected cause of growth failure, immunodeficiency, and severe pulmonary disease","volume":"158","author":"Nadeau","year":"2011","journal-title":"J. Pediatr."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1020","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1210\/jc.2004-1254","article-title":"Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation","volume":"90","author":"Walenkamp","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1025","doi-asserted-by":"crossref","first-page":"363","DOI":"10.15252\/emmm.201506106","article-title":"Mutations in pregnancy-associated plasma protein A2 cause short stature due to low IGF-I availability","volume":"8","author":"Dauber","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1030","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1210\/jc.2014-1506","article-title":"Genetic evaluation of short stature","volume":"99","author":"Dauber","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1035","first-page":"40","article-title":"Evaluation of insulin-like growth factor-1 and insulinlike growth factor binding protein-3 in diagnosis of growth hormone deficiency in short-stature children","volume":"21","author":"Ali","year":"2009","journal-title":"J. Ayub Med. Coll. Abbottabad"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1040","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1046\/j.1365-2265.2000.01145.x","article-title":"Serum levels of free insulin-like growth factor (IGF)-I and IGF-binding protein-1 in prepubertal children with idiopathic short stature","volume":"53","author":"Kamoda","year":"2000","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1045","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1515\/JPEM.1996.9.3.415","article-title":"Short stature and low IGF-1 and IGFBP-3 despite normal growth hormone secretion in a 4 year-old girl with primary empty sella syndrome","volume":"9","author":"D\u00f6tsch","year":"1996","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"October","key":"10.1016\/j.cytogfr.2017.12.004_bib1050","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1530\/acta.0.1270351","article-title":"Growth hormone and insulin-like growth factor regulate insulin-like growth factor-binding protein-1 in Laron type dwarfism, growth hormone deficiency and constitutional short stature","volume":"127","author":"Laron","year":"1992","journal-title":"Acta Endocrinol."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1055","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1055\/s-2007-1003383","article-title":"Insulin-like growth factor binding protein 1 (IGFBP-1) levels in Turner syndrome","volume":"24","author":"Cianfarani","year":"1992","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1060","first-page":"3534","article-title":"Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy","volume":"83","author":"Barreca","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1065","first-page":"1294","article-title":"Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children","volume":"77","author":"Smith","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1070","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00467-004-1658-y","article-title":"The multi-functional role of insulin-like growth factor binding proteins in bone","volume":"20","author":"Govoni","year":"2005","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13148-016-0178-5","article-title":"Insulin-like growth factor axis in pregnancies affected by fetal growth disorders","volume":"8","author":"Nawathe","year":"2016","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1080","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3109\/00365513.2013.771281","article-title":"Reference change values for insulin and insulin-like growth factor binding protein-1 (IGFBP-1) in individuals with varying degrees of glucose tolerance","volume":"73","author":"Borai","year":"2013","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2009.11.007","article-title":"Antidiabetic effects of IGFBP2, a leptin-regulated gene","volume":"11","author":"Hedbacker","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1090","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1530\/EC-13-0065","article-title":"3-M syndrome: a growth disorder associated with IGF2 silencing","volume":"2","author":"Murray","year":"2013","journal-title":"Endocr. Connect."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1095","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1210\/edrv-15-3-369","article-title":"Growth hormone (GH) insensitivity due to primary GH receptor deficiency","volume":"15","author":"Rosenfeld","year":"1994","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1100","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJMoa1415227","article-title":"Paternally inherited IGF2 mutation and growth restriction","volume":"373","author":"Begemann","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1105","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0022-3476(95)70302-0","article-title":"Evidence for partial growth hormone insensitivity among patients with idiopathic short stature. The National Cooperative Growth Study","volume":"127","author":"Attie","year":"1995","journal-title":"J. Pediatr."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1110","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJM199510263331701","article-title":"Mutations of the growth hormone receptor in children with idiopathic short stature. The Growth Hormone Insensitivity Study Group","volume":"333","author":"Goddard","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1115","doi-asserted-by":"crossref","first-page":"e88766","DOI":"10.1172\/jci.insight.88766","article-title":"Insulin resistance uncoupled from dyslipidemia due to C-terminal PIK3R1 mutations","volume":"1","author":"Huang-Doran","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1120","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1471-2350-15-51","article-title":"Exome sequencing identifies a novel mutation in PIK3R1 as the cause of SHORT syndrome","volume":"15","author":"B\u00e1rcena","year":"2014","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1125","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ajhg.2013.05.019","article-title":"PIK3R1 mutations cause syndromic insulin resistance with lipoatrophy","volume":"93","author":"Thauvin-Robinet","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1130","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ajhg.2013.05.023","article-title":"SHORT syndrome with partial lipodystrophy due to impaired phosphatidylinositol 3 kinase signaling","volume":"93","author":"Chudasama","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1135","doi-asserted-by":"crossref","first-page":"38349","DOI":"10.1074\/jbc.C100462200","article-title":"Akt1\/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice","volume":"276","author":"Cho","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1140","first-page":"315","article-title":"Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis","volume":"119","author":"Semple","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1145","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1126\/science.292.5522.1728","article-title":"Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta)","volume":"292","author":"Cho","year":"2001","journal-title":"Science"},{"issue":"Suppl. 825.1","key":"10.1016\/j.cytogfr.2017.12.004_bib1150","article-title":"Effects of aging on insulin action and AKT signaling in isoform specific AKT knockout mice","volume":"25","author":"Reynolds","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1155","doi-asserted-by":"crossref","first-page":"35298","DOI":"10.1074\/jbc.M405203200","article-title":"Insulin resistance due to phosphorylation of insulin receptor substrate-1 at serine 302","volume":"279","author":"Werner","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1160","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s001250051628","article-title":"The G972R variant of the insulin receptor substrate-1 (IRS-1) gene: body fat distribution and insulin-resistance","volume":"44","author":"Baroni","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1165","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.2337\/diabetes.52.9.2239","article-title":"Molecular mechanisms of insulin resistance in IRS-2-deficient hepatocytes","volume":"52","author":"Valverde","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1170","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1128\/MCB.01661-08","article-title":"Deletion of Shp2 tyrosine phosphatase in muscle leads to dilated cardiomyopathy, insulin resistance, and premature death","volume":"29","author":"Princen","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1175","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ymgmr.2013.12.006","article-title":"Sequencing analysis of insulin receptor defects and detection of two novel mutations in INSR gene","volume":"1","author":"Ardon","year":"2014","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1180","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/hmg\/11.12.1465","article-title":"Genotype\u2013phenotype correlation in inherited severe insulin resistance","volume":"11","author":"Longo","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1185","first-page":"799","article-title":"Impaired growth in Rabson-Mendenhall syndrome: lack of effect of growth hormone and insulin-like growth factor-I","volume":"79","author":"Longo","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1190","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0022-3476(54)80113-2","article-title":"Leprechaunism: a euphemism for a rare familial disorder","volume":"45","author":"Donohue","year":"1954","journal-title":"J. Pediatr."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1195","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","article-title":"Treatment of HCV infection by targeting microRNA","volume":"368","author":"Janssen","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1200","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrd3864","article-title":"MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles","volume":"11","author":"van Rooij","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cytogfr.2017.12.004_bib1205","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.cell.2009.04.021","article-title":"Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model","volume":"137","author":"Kota","year":"2009","journal-title":"Cell"}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610117301958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610117301958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T20:45:46Z","timestamp":1660423546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610117301958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":241,"alternative-id":["S1359610117301958"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2017.12.004","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNAs link chronic inflammation in childhood to growth impairment and insulin-resistance","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2017.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}